» Articles » PMID: 9023387

Changes in Radiation Sensitivity and Steroid Receptor Content Induced by Hormonal Agents and Ionizing Radiation in Breast Cancer Cells in Vitro

Overview
Journal Acta Oncol
Specialty Oncology
Date 1996 Jan 1
PMID 9023387
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Possible influences of tamoxifen and estradiol on in vitro radiation sensitivity and cellular receptor content after irradiation and/or tamoxifen treatment were studied in breast cancer cell lines; estrogen receptor (ER) and progesterone receptor (PgR) positive cell lines MCF-7 and MCF-7/TAM(R)-1 and the ER and PgR negative cell line MDA-MB-231. The tamoxifen resistant MCF-7/TAM(R)-1 cells were more resistant to ionizing radiation than the MCF-7 and MDA-MB-231 cells. Exposure to tamoxifen made the MCF-7 cells more radiation resistant, while estradiol made the MDA-MB-231 cells more radiation sensitive. A radiation dose of 6 Gy reduced the ER content in cytosol in both MCF-7 and MCF-7/TAM(R)-1 cells, but brought no alterations to the PgR content. In MCF-7/TAM(R)-1 cells tamoxifen exposure significantly increased the ER and reduced the PgR content, an effect not observed in the MCF-7 cells. To conclude, the present study indicates that irradiation and tamoxifen may modify the ER and PgR content in cytosol in breast cancer cells. Hormonal treatment may alter the radiation sensitivity, even in ER negative cells, suggesting that hormonal agents may act both via receptor and non-receptor binding mechanisms.

Citing Articles

Irreversible inhibition of estrogen receptor α signaling and the emergence of hormonal resistance in MCF7 breast cancer cells induced by DNA damage agents.

Scherbakov A, Sorokin D, Razuvaeva V, Shchegolev Y, Andreeva O, Salnikova D Biomed Rep. 2024; 20(3):42.

PMID: 38343657 PMC: 10853760. DOI: 10.3892/br.2024.1727.


Considerations of Medical Preparedness to Assess and Treat Various Populations During a Radiation Public Health Emergency.

Winters T, Cassatt D, Harrison-Peters J, Hollingsworth B, Rios C, Satyamitra M Radiat Res. 2023; 199(3):301-318.

PMID: 36656560 PMC: 10120400. DOI: 10.1667/RADE-22-00148.1.


Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer.

Post A, Bussink J, Sweep F, Span P Oncol Res. 2019; 28(1):33-40.

PMID: 31046897 PMC: 7851527. DOI: 10.3727/096504019X15555794826018.


Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.

Bravata V, Cava C, Minafra L, Cammarata F, Russo G, Gilardi M Int J Mol Sci. 2018; 19(4).

PMID: 29617354 PMC: 5979377. DOI: 10.3390/ijms19041084.


Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies.

Rong C, Meinert E, Hess J Int J Mol Sci. 2018; 19(3).

PMID: 29498642 PMC: 5877574. DOI: 10.3390/ijms19030713.